Will ‘open-source’ vaccines narrow the inequality gap exposed by Covid?

Professor Matthew Todd (UCL School of Pharmacy), who has co-founded an open-source pharmaceuticals initiative to drive development of new medications, says the Covid-19 pandemic has ramped up global collaboration in drug development.

Read: FT